A

Anixa Biosciences
D

ANIX

3.31000
USD
-0.03
(-0.90%)
Market Closed
Volume
791
EPS
-0
Div Yield
-
P/E
-8
Market Cap
106,514,119
News

Title: Anixa Biosciences

Sector: Healthcare
Industry: Biotechnology
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.